Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
ID: 332526Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/332526

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-211.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for pilot effectiveness trials aimed at evaluating post-acute interventions for mental health conditions. The primary objective is to assess the feasibility, safety, acceptability, and preliminary effectiveness of therapeutic and service delivery interventions designed to optimize long-term outcomes following acute treatment. This initiative is particularly significant as it seeks to address mental health disparities among underserved populations and aims to gather essential data for future large-scale effectiveness trials, with a total funding cap of $450,000 over a three-year period. Interested applicants must submit their proposals by January 25, 2025, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the application process.

    Point(s) of Contact
    FBOWebmaster@OD.NIH.GOV
    Files
    Title
    Posted
    PAR-21-211-Full-Announcement.html
    PAR-21-211.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Mental Health (NIMH), is issuing a funding opportunity for pilot effectiveness trials (R34 Clinical Trial Required) focused on post-acute interventions for mental health conditions. The aim is to assess therapeutic and service delivery interventions intended to optimize long-term outcomes post-acute treatment by evaluating their feasibility, safety, acceptability, and preliminary indications of effectiveness. This funding initiative follows previous announcements and is designed to gather essential data for future large-scale effectiveness trials (supported under R01). The program targets a wide audience, including higher education institutions, nonprofits, and government entities, highlighting the need for research specifically addressing mental health disparities among underserved populations. The overall project budget is capped at $450,000 over a three-year period, with specific deadlines set for application submissions. The request emphasizes adherence to application instructions while encouraging the utilization of existing research infrastructures to improve recruitment and data collection efficiency. This opportunity underlines the commitment to enhance mental health outcomes through rigorous research and knowledge advancement.
    Similar Opportunities
    Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for research projects aimed at evaluating the effectiveness of post-acute interventions and services for mental health conditions affecting youth, adults, and older adults. This initiative encourages clinical trials designed to assess therapeutic strategies that consolidate treatment gains, manage residual symptoms, prevent relapse, and enhance treatment adherence, with a focus on producing statistically powered studies that address chronic or relapsing mental health issues. The program emphasizes the importance of improving long-term mental health outcomes, particularly for underserved populations, and applications are open to a diverse range of eligible entities, including educational institutions and community organizations. Interested applicants should note that the deadline for submissions is January 25, 2025, and can find further details and guidelines at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for pilot effectiveness trials focused on treatment, preventive, and services interventions in mental health, under the title "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)." This initiative aims to support studies that optimize the effectiveness of previously validated interventions for broader populations and community settings, as well as to develop and preliminarily test innovative service interventions that engage the underlying mechanisms of their effects. With a total funding amount of $27 million for FY 2022, the program encourages diverse methodologies, including hybrid effectiveness-implementation trials, and emphasizes the importance of empirical justification for adaptations to existing interventions. Interested applicants must submit their proposals by October 15, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries.
    Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the R01 grant to support clinical trials aimed at evaluating the effectiveness of treatment, preventive, and service interventions in mental health. The primary objectives of this funding opportunity include conducting rigorous assessments of pharmacologic, psychosocial, and combined interventions, as well as service-level strategies that enhance access and quality of mental health care within community settings. This initiative is crucial for addressing significant public health challenges and advancing evidence-based practices in mental health service delivery. The total funding available is $27 million, with a maximum project period of five years, and applications are due by October 15, 2024. For further information, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-21-130.html.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for the Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). This initiative aims to support pilot research focused on innovative psychosocial intervention strategies for both adults and children, emphasizing the experimental therapeutic approach to address underlying mechanisms of mental disorders. The funding will facilitate exploratory clinical trials for up to three years, with no specific budget limits, provided they reflect actual project needs, and applications must demonstrate a strong scientific rationale and empirical support. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of October 15, 2024.
    Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required). This initiative aims to support innovative clinical trials that investigate novel interventions for mental health conditions, including schizophrenia, depression, and anxiety, with a focus on establishing proof of mechanism and target engagement in the R61 phase and confirming findings on a larger scale in the R33 phase. The total funding commitment for this initiative is $27 million for FY 2022, and eligible applicants include a diverse range of entities such as higher education institutions, nonprofits, and various government organizations, both domestic and foreign. Interested parties should note that the application deadline is October 15, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries.
    Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)." This initiative aims to stimulate innovative pilot research that enhances the quality and accessibility of mental health services, particularly for underserved populations, by encouraging projects that identify factors affecting service delivery and assess new technologies without the need for clinical trials. The funding opportunity is open to a wide range of eligible applicants, including higher education institutions, nonprofits, and governmental entities, with a budget cap of $450,000 over a maximum project period of three years. Interested applicants should submit their proposals by May 7, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is inviting applications for the Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) grant. This funding opportunity aims to support clinical trials that assess the efficacy of non-pharmacological interventions for mental disorders in both adults and children, focusing on addressing unmet therapeutic needs and enhancing understanding of the mechanisms of action through rigorous experimental therapeutics approaches. The NIMH plans to commit approximately $27 million to fund various companion funding opportunities, with applications due by October 15, 2024. Interested applicants can find additional information and application procedures at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders" (R61/R33 Clinical Trial Required). This initiative aims to support pilot research that develops and tests innovative psychosocial interventions targeting mental disorders in both adults and children, focusing on early-stage exploratory clinical trials to assess how these interventions engage biological, cognitive, or behavioral targets linked to mental health issues. Successful projects will receive funding for up to two years in the R61 phase for preliminary studies, with the potential for an additional three years in the R33 phase contingent upon meeting specified milestones. Interested applicants must adhere to strict guidelines regarding human subject protections and submit their applications through Grants.gov by the deadline of October 15, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.
    Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a funding opportunity titled "Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)." This grant aims to support innovative research that enhances the delivery and quality of mental health services, particularly for underserved populations, by addressing issues such as access, usability, quality, and scalability of these services. Eligible applicants include a wide range of organizations, including educational institutions, non-profits, and governmental bodies, with a focus on projects that incorporate community input and comply with NIH guidelines. Interested parties should note that the application deadline is January 7, 2025, and further details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-095.html. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH)" through a cooperative agreement aimed at advancing research in mental health. The initiative seeks to develop and optimize behavioral tasks that measure individual differences, enhancing clinical prediction and decision-making through the integration of behavioral measures and computational methods. This funding is crucial for fostering innovative clinical signatures that can improve the assessment and treatment of mental disorders, with a total funding amount of $15 million anticipated for FY 2025, allowing for up to six awards of $2.5 million each over a maximum project duration of five years. Interested applicants must submit their proposals by October 18, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.